HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

Similar documents
12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS

Commonly Asked Questions About Chronic Hepatitis C

Are you Hep C aware? awareness information support prevention To find out more visit

The Epidemiology of Hepatitis A, B, and C

GUIDELINES FOR VIRAL HEPATITIS SURVEILLANCE AND CASE MANAGEMENT

GUIDELINES FOR THE MANAGEMENT OF HEPATITIS C

Viral Hepatitis APHL survey report

Viral Hepatitis Case Report

2015 Outpatient Chronic Hepatitis B Management

Treatment of Acute Hepatitis C

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

THE A, B, C S OF HEPATITIS. Matt Eidem, M.D. Digestive Health Associates of Texas 1600 Coit Road Suite #301 Plano, Texas (972)

Molecular Diagnosis of Hepatitis B and Hepatitis D infections

Viral Hepatitis A, B, and C

Appendix B: Provincial Case Definitions for Reportable Diseases

Newly Diagnosed: HEPATITIS C. American Liver Foundation Support Guide

Hepatitis C: Epidemiology, Transmission, and Screening. Jennifer Price, MD Assistant Professor of Medicine University of California San Francisco

The most serious symptoms of this stage are:

Case Finding for Hepatitis B and Hepatitis C

HBV DNA < monitoring interferon Rx

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

HEPATITIS C. The Facts. Get Tested. Get Cured! Health

Preface. TTY: (888) or Hepatitis C Counseling and Testing, contact: 800-CDC-INFO ( )

Hepatitis C Infections in Oregon September 2014

Guidelines for Managing Exposures to Blood Borne Pathogens

POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING

Guidelines for Viral Hepatitis CTR Services

PERINATAL AND CHILDHOOD HEPATITIS.. WHAT ABOUT THE CHILDREN?

João Silva de Mendonça, MD, PhD Infectious Diseases Service Hospital do Servidor Público Estadual São Paulo - Brazil

Hepatitis C 1) THE DISEASE AND ITS EPIDEMIOLOGY

Hospitalizations for Hepatitis A, B, and C, Active Component, U.S. Armed Forces,

Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis

english facts about hepatitis A, B and C

Beginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice

A P P E N D I X SAMPLE FORMS

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS

When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management

Hepatitis C. Screening, Diagnosis and Linkage to Care

POST EXPOSURE MANAGEMENT: HEPATITIS B, HEPATITIS C AND HIV

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK

Information about hepatitis C for patients and carers

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

3/25/2014. April 3, Dennison MM, et al. Ann Intern Med. 2014;160:

Global Under Diagnosis of Viral Hepatitis

HEPATITIS A, B, AND C

National Health Burden of CLD in Italy

Title: Post Exposure Prophylaxis Page 1 of 8 Policy No: 1 CLN 010 Effective Date 04/15/11

AIR FORCE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS

Appendix 3 Exposure Incident Report Form

POSTEXPOSURE PROPHYLAXIS

Didactic Series. Updated Post-Exposure Prophylaxis (PEP) Guidelines. Daniel Lee, MD UCSD Medical Center, Owen Clinic January 9, 2014

OCCUPATIONAL HEALTH, DISABILITY AND LEAVE SECTOR MEASURES TO MINIMIZE EXPOSURE TO BLOODBORNE PATHOGENS AND POST-EXPOSURE PROPHYLAXIS POLICY

Results Demographic profile of these children is shown in Table I.

Hepatitis C. Eliot Godofsky, MD University Hepatitis Center Bradenton, FL

Transmission of HCV in the United States (CDC estimate)

Bloodborne Pathogens

1.How did I get Hepatitis C?

Hepatitis C Monitoring and Complications (and Treatment!) Dr Mark Douglas

Update on Hepatitis C. Sally Williams MD

Hepatitis C. Laboratory Tests and Hepatitis C

Managing Bloodborne Pathogens Exposures

Exposure. What Healthcare Personnel Need to Know

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

California Adult Viral Hepatitis Prevention. Strategic Plan,

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

Needle-Stick Policy.

What you should. know

Body Fluid Exposure:

Hepatitis C Virus Infection in Massachusetts: A tale of two epidemics

Coding and Billing for HIV Services in Healthcare Facilities

UCSF Communicable Disease Surveillance and Vaccination Policy

Kean University BS Degree Program in Athletic Training BLOOD BORN PATHOGENS POLICY

Hepatitis Update Brendan M. McGuire, MD UAB Liver Center

HCV in 2020: Any cases left? Rafael Esteban Hospital General Universitario Valle Hebron Barcelona. Spain

INFORMATION ABOUT HEPATITIS C

Protocol for Needle Stick Injuries Occurring to NY Medical College Students In Physicians Offices

WHY ARE WE HERE? OSHA BB Pathogen standard. The more you know, the better you will perform in real situations!

Management of non response or relapse following HCV therapy. Greg Dore Darrell Crawford

Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During

HIV and Hepatitis B CoInfection

Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action

Albumin. Prothrombin time. Total protein

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

DISEASES SPREAD THROUGH BLOOD AND BODY FLUIDS

Review: How to work up your patient with Hepatitis C

New IDSA/AASLD Guidelines for Hepatitis C

Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013

Co-infected health-care workers

GUIDE TO FOLLOW UP TESTING FOR BLOOD OR BODY FLUID EXPOSURES AND NEEDLESTICK INJURIES

Patient Information Sheet

Transcription:

HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School of Medicine March 11, 2013

Disclosure Information No disclosures to report

Acute C: Epidemiology

Incidence of Acute C, by year United States, 1982-2010 60,000 Estimated Number of Cases 50,000 40,000 30,000 20,000 10,000 0 Source: CDC Division of Viral. Statistics and Surveillance.

Reported Number of Acute HCV Cases United States, 2000-2010 3,500 3,000 Number of Cases 2,500 2,000 1,500 1,000 500 0 2000 2002 2004 2006 2008 2010 Year Source: National Notifiable Diseases Surveillance System (NNDSS)

C Incident Cases in 2010 17,000 estimated new HCV infections per year in U.S. 2,800 cases with symptomatic acute HCV 853 cases of acute HCV actually reported Source: CDC Division of Viral. Statistics and Surveillance.

Rationale for Identifying Patients with Acute HCV Provide risk reduction counseling and linkage to care Shift dynamics of natural history of HCV disease

C Transmission Bloodborne transmission is the most common route Sexual transmission in general population considered rare - Among cohort of 895 heterosexual HCV-serodiscordant couples, only 3 transmissions occurred à incidence 0.37/1000 person-years - Strain analysis did not support sexual transmission Increasing reports of HIV-infected men who have sex with men with sexually-acquired acute HCV infection in Europe, Australia, and U.S. Source: Vandelli C, et al. Am J Gastroenterol. 2004;99:855-9.

List of Potential C Exposures Potential Source of Exposure to C Virus Recent injection drug use Needle stick injury Procedures involving potentially reused needles: tattooing, body-piercing, acupuncture Exposure to re-used sharp objects or re-used vials of injectable materials Nosocomial exposure to contaminated equipment, or potential direct exposure to blood High risk sexual practices: fisting, bleeding during sex, use of sharp objects during sex Sexual contact with a known HCV-infected partner Sexual contact with known HIV positive partner Sexual contact with known sexually transmitted infections in patient or their partner Blood transfusion or unsafe therapeutic procedures during travel in a developing country

Diagnosis

Diagnosis of Acute C Acute HCV = first 6 months of infection Diagnosis of acute HCV can be challenging: - Most cases asymptomatic - No reliable or specific IgM-based HCV antibody test

Acute C: 2012 CDC Case Definition Acute C: 2012 Case Definition Clinical Presentation An acute illness consistent with acute viral hepatitis AND Jaundice/dark urine or ALT greater than 400 IU/L Laboratory Criteria for Diagnosis Meets 1 of the following 3 criteria: HCV EIA positive, OR HCV RIBA positive, OR HCV RNA positive AND Negative HAV IgM AND negative HBV IgM anti-hbc Source: CDC and Prevention

Diagnosis of Acute C C RNA quantitative (or qualitative) assay - Can detect HCR RNA as early as 1 week from time of infection - Most sensitive early test - Levels can fluctuate widely in acute infection - Best to use assay with low limit of detection (<10-15 IU/mL) Serum ALT - Elevated in range of 400-800 U/L for symptomatic patients - Any new elevation (typically >7X ULN) C antibody (by standard EIA) - Lags behind HCV RNA - In most patients, detected x 2-4 months from time of infection - Not as sensitive: only 50-70% acutely infected are HCV Ab (+) - Helpful if seroconversion has occurred

Spontaneous Clearance of HCV after Acute Infection +/- Symptoms HCV RNA ALT Anti-HCV HCV Infection Source: www.hepwebstudy.org 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Weeks

HCV Persistence after Acute Infection +/- Symptoms HCV RNA ALT Anti-HCV HCV Infection Source: www.hepwebstudy.org 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Weeks

Distribution of HCV RNA Levels for Acute versus Chronic HCV Percent of All Patients (%) 40 30 20 10 16.0 Acute Chronic 8.0 13.0 25.0 7.9 20.0 16.5 11.0 26.1 7.0 30.2 14.3 0 1.3 1.9 1.9 0.0 <3.5 4.0 4.5 5.0 5.5 6.0 6.5 >6.5 Baseline HCV RNA concentration, log 10 IU/ml Source: McGovern BH, et al. Clin Infect Dis. 2009;49:1051-60.

Clinical Features & Natural History

Acute C Clinical Features Among 51 Patients with Acute HCV Infection 100 80 68 Patients (%) 60 40 55 39 34 25 20 0 Jaundice Flu-Like Symptoms Dark Urine & White Stool Nausea Abdominal Pain Source: Gerlach JT, et al. Gastroenterology. 2003;125:80-8.

Acute C Clinical Features Among 24 Patients with Acute HCV Infection 100 80 Patients (%) 60 40 63 50 38 20 17 0 Fatigue Jaundice Dyspepsia Abdominal Pain Source: Santantonio T, et al. Dig Liver Dis. 2003;35:104-13.

Natural History of Acute HCV Infection Incubation period = 4-14 weeks - Most with acute HCV are asymptomatic or minimally symptomatic - Only 10-20% have a distinct clinical illness If clinical illness occurs, hepatitis is rarely fulminant - ALT typically 400-1000 U/L - Bilirubin rarely >12 mg/dl Two possible outcomes: - Spontaneous clearance: estimated at 20-25% (may be lower in HIV-infected) - Persistent chronic HCV infection. Source: Low, et. al. AIDS Reviews 2008; 10:245-53.

Predictors of Spontaneous HCV Clearance Lower peak HCV RNA levels Rapid early decline in HCV viral level High ALT Presence of jaundice Female gender Younger age Non-black race Coinfection with chronic hep B (+HBsAg) IL28B CC homozygous genotype

Genetic Variation in IL28-B and Spontaneous HCV Clearance 100 Spontaneous Clearance of HCV (%) 80 60 53.0 40 29.5 23.4 20 0 T/T C/T C/C Genotype Source: Thomas DT, et al. Nature. 2009;461:798-802.

Genetic Variation in IL28-B and Spontaneous HCV Clearance 100 80 T/T C/T C/C P = 4 x 10-7 P = 0.04 P = 3 x 10-7 Clearance (%) 60 40 20 0 All European Ancestry African Ancestry Source: Thomas DT, et al. Nature. 2009;461:798-802.

Acute C: Summary Often a missed diagnosis! Contaminated blood exposure is the most common but sexual transmission can occur Confirmation of acute hepatitis C can be challenging since minority (10-20%) of patients have clinical symptoms HCV RNA, serum ALT and HCV antibody testing remain the cornerstone of acute HCV diagnosis Spontaneous clearance can occur in some acutely infected patients but the majority (75%) will go onto chronic infection if untreated.

End This presentation is brought to you by Web Study & the C Online Course Funded by a grant from the Centers for Disease Control and Prevention